Status:
COMPLETED
Evaluation of the TRANSEND Program
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Pediatric Patient Transfer to Adult Service:Transition Program
Eligibility:
All Genders
18-32 years
Brief Summary
"Transend" is a program designed to promote the transition of young patients with endocrine or metabolic diseases when they arrive in the adult sector at La Pitié-Salpétrière hospital. The main object...
Detailed Description
Adolescence and early adulthood represent important periods for young people suffering from chronic diseases. Several observational studies show needs not covered by care services at this period and s...
Eligibility Criteria
Inclusion
- Patient aged 18 to 32
- Patient with endocrine or metabolic disease
- Patient who had a follow-up in a pediatric department for his endocrine or metabolic disease
- Patient transferred to the adult sector in the endocrinology, metabolism or nutrition department of Pitié-Salpêtrière
- Patient who had a first post-transfer consultation between January 1, 2015 and September 1, 2017
- Patient with a social security protection
Exclusion
- Patient who transferred to another adult service before being followed at Pitié-Salpêtrière
- Patient who has expressed his opposition to participate in this research
Key Trial Info
Start Date :
September 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 10 2020
Estimated Enrollment :
202 Patients enrolled
Trial Details
Trial ID
NCT04277286
Start Date
September 9 2020
End Date
October 10 2020
Last Update
March 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chef du Service d'Endocrinologie et Médecine de le Reproduction, Hôpital de la Pitié-Salpêtrière
Paris, France, 75013